- Home
- WXM vs PLRZ Comparison
WXM vs PLRZ Comparison
Compare WXM & PLRZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WXM
- PLRZ
- Stock Information
- Founded
- WXM 2009
- PLRZ 2005
- Country
- WXM China
- PLRZ Israel
- Employees
- WXM N/A
- PLRZ N/A
- Industry
- WXM
- PLRZ
- Sector
- WXM
- PLRZ
- Exchange
- WXM NYSE
- PLRZ NYSE
- Market Cap
- WXM 15.3M
- PLRZ 14.7M
- IPO Year
- WXM 2025
- PLRZ 2024
- Fundamental
- Price
- WXM $2.10
- PLRZ $0.36
- Analyst Decision
- WXM
- PLRZ
- Analyst Count
- WXM 0
- PLRZ 0
- Target Price
- WXM N/A
- PLRZ N/A
- AVG Volume (30 Days)
- WXM 892.8K
- PLRZ 542.4K
- Earning Date
- WXM 01-01-0001
- PLRZ 02-15-2025
- Dividend Yield
- WXM N/A
- PLRZ N/A
- EPS Growth
- WXM 67.61
- PLRZ N/A
- EPS
- WXM 0.18
- PLRZ N/A
- Revenue
- WXM $15,524,259.00
- PLRZ N/A
- Revenue This Year
- WXM N/A
- PLRZ N/A
- Revenue Next Year
- WXM N/A
- PLRZ N/A
- P/E Ratio
- WXM $12.00
- PLRZ N/A
- Revenue Growth
- WXM 10.86
- PLRZ N/A
- 52 Week Low
- WXM $1.52
- PLRZ $0.28
- 52 Week High
- WXM $7.99
- PLRZ $4.80
- Technical
- Relative Strength Index (RSI)
- WXM N/A
- PLRZ N/A
- Support Level
- WXM N/A
- PLRZ N/A
- Resistance Level
- WXM N/A
- PLRZ N/A
- Average True Range (ATR)
- WXM 0.00
- PLRZ 0.00
- MACD
- WXM 0.00
- PLRZ 0.00
- Stochastic Oscillator
- WXM 0.00
- PLRZ 0.00
About WXM WF INTERNATIONAL LIMITED
WF International Ltd is engaged in the provision of supply, installation, fitting-out and maintenance services for HVAC system and floor heating systems. It provides the supply, installation and fitting-out services for HVAC systems for large-scaled commercial projects consisting of offices, hotels, manufactures, airports and hospitals, such as the International Finance Square HVAC projects across China, Chengdu Vanke Charm City, Chengdu Raffles Plaza, Chengdu Yinshi Plaza, Chengdu Metro No. Ten Line, and Panzhihua Jinhai Hotel.
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.